Our researchers regularly share the results of their research. They are authors or co-authors of numerous scientific publications or presentations intended for a wider audience. You will find them below.

ABSTRACTS

ABSTRACT
M. Buchanan, C. Chabot... J-F Boileau, C. Ferrario, G. Batist, A. Aguilar-Mahecha, M. Basik et al.

Use of PDXs and patient derived cell lines to uncover unconventional drug therapies and combinations for the treatment of drug resistant cancers

DOI: 10.1158/1538-7445.AM2018-2149 Published July 2018

LINK
PDF
ABSTRACT
S. Tolaney, J. Blum … M. Pavic et al.

CONTESSA TRIO: A Multinational, Multicenter, Phase 2 Study of Tesetaxel plus 3 Different PD-(L)1 Inhibitors in Patients with Metastatic Triple-Negative Breast Cancer (TNBC) and Tesetaxel Monotherapy in Elderly Patients with HER2- Metastatic Breast Cancer (MBC)

DOI: 10.1093/annonc/mdz242.077

LINK
PDF

ARTICLES

ARTICLE
S. Michaud, J. Needham, D. Johnson, … B. D. Stein et al.

Patient and Patient Group Engagement in Cancer Clinical Trials: A Stakeholder Charter

DOI: 10.3390/curroncol28020137

LINK
PDF
ARTICLE
S. Hassan, R. Younan, E. Patocskai, L. Provencher, ... A. Robidoux et al.

Impact of the 21-Gene Recurrence Score Assay on Treatment Decisions and Cost in Patients with Node-Positive Breast Cancer: A Multicenter Study in Quebec

DOI: 10.1093/oncolo/oyac123

LINK

POSTERS

POSTER
M. Yordonova, L. Sideris, P. Dubé... S. Hassan et al

The impact of the 21-gene Breast Recurrence Score® assay upon physician treatment recommendations in the neoadjuvant setting in lymph node-negative breast cancer patients in Quebec

 

LINK